From one of the first experts to describe problems with benzodiazepines in the scientific literature

World Benzodiazepine Awareness day has become an annual event, a development that I welcome and endorse. Too often interest is stimulated in an on-going and difficult medical problem only to subside as people move on to something else. The problem of iatrogenic, normal-dose benzodiazepine dependence is not lessening; concern must continue and even increase. I thank those who are involved for this initiative.